Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol

High blood pressure is the leading cause of preventable morbidity and mortality globally. Many patients remain on single-drug treatment with poor control, although guidelines recognize that most require combination therapy for blood pressure control. Our hypothesis is that a single-pill combination...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am Heart J
Auteurs principaux: Chow, Clara K., Atkins, Emily R., Billot, Laurent, Chalmers, John, Hillis, Graham S., Hay, Peter, Neal, Bruce, Nelson, Mark, Patel, Anushka, Reid, Christopher M., Schlaich, Markus, Usherwood, Tim, Webster, Ruth, Rodgers, Anthony
Format: Artigo
Langue:Inglês
Publié: Published by Elsevier Inc. 2021
Sujets:
Trial Designs
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531985/
https://ncbi.nlm.nih.gov/pubmed/33017580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2020.09.017
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires